PUBLISHER: TechNavio | PRODUCT CODE: 2110106
PUBLISHER: TechNavio | PRODUCT CODE: 2110106
Global Postbiotic Market 2026-2030
The global postbiotic market is forecasted to grow by USD 82284.7 thousand during 2025-2030, accelerating at a CAGR of 9.1% during the forecast period. The report on the global postbiotic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by proliferation of consumer awareness regarding human microbiome and preventive health, superior technological stability and versatile formulation capabilities, increasing utilization in animal nutrition and veterinary applications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 8.9% |
| CAGR | 9.1% |
| Incremental Value | $82284.7 thousand |
Technavio's global postbiotic market is segmented as below:
By Application
- Food and beverages
- Dietary supplements
- Pharmaceuticals
- Animal nutrition
- Personal care and cosmetics
By Source
- Bacteria
- Yeast
By Type
- Dry
- Liquid
Geography
- Asia
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- North America
- US
- Canada
- Mexico
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of postbiotics in dermatological and cosmeceutical applications as one of the prime reasons driving the global postbiotic market growth during the next few years. Also, expansion of postbiotics into active lifestyle and sports nutrition formulations and regulatory standardization and clinical validation enhancing commercial credibility will lead to sizable demand in the market.
The report on the global postbiotic market covers the following areas:
- Global postbiotic market sizing
- Global postbiotic market forecast
- Global postbiotic market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global postbiotic market vendors that include Adare Pharma Solutions, Archer Daniels Midland Co., BIO CAT Inc., Biorigin S.A., Cargill Inc., DSM Firmenich AG, GeneFerm Biotechnology Co. Ltd, International Flavors Inc., Kaneka Corp., Kerry Group Plc, KitoZyme LLC, Lallemand Inc., Lesaffre Group, Novonesis Group, Ohly GmbH, POSTBIOTICA S.R.L., Probi AB, Sabinsa Corp., Symrise Group, Unique Biotech Ltd.. Also, the global postbiotic market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Postbiotic Market 2020 - 2024
- Historic Market Size - Data Table on Global Postbiotic Market 2020 - 2024 ($ thousand)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ thousand)
- 5.3 Source segment analysis 2020 - 2024
- Historic Market Size - Source Segment 2020 - 2024 ($ thousand)
- 5.4 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Postbiotic Market
- 6.2 Impact of Geopolitical Conflicts on Global Postbiotic Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Food and beverages - Market size and forecast 2025-2030
- 8.4 Dietary supplements - Market size and forecast 2025-2030
- 8.5 Pharmaceuticals - Market size and forecast 2025-2030
- 8.6 Animal nutrition - Market size and forecast 2025-2030
- 8.7 Personal care and cosmetics - Market size and forecast 2025-2030
- 8.8 Market opportunity by Application
- Market opportunity by Application ($ thousand)
9 Market Segmentation by Source
- 9.1 Market segments
- 9.2 Comparison by Source
- 9.3 Bacteria - Market size and forecast 2025-2030
- 9.4 Yeast - Market size and forecast 2025-2030
- 9.5 Market opportunity by Source
- Market opportunity by Source ($ thousand)
10 Market Segmentation by Type
- 10.1 Market segments
- 10.2 Comparison by Type
- 10.3 Dry - Market size and forecast 2025-2030
- 10.4 Liquid - Market size and forecast 2025-2030
- 10.5 Market opportunity by Type
- Market opportunity by Type ($ thousand)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 Asia - Market size and forecast 2025-2030
- 12.3.1 China - Market size and forecast 2025-2030
- 12.3.2 Japan - Market size and forecast 2025-2030
- 12.3.3 India - Market size and forecast 2025-2030
- 12.3.4 South Korea - Market size and forecast 2025-2030
- 12.3.5 Indonesia - Market size and forecast 2025-2030
- 12.3.6 Thailand - Market size and forecast 2025-2030
- 12.3.7 Singapore - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.4.7 Russia - Market size and forecast 2025-2030
- 12.5 North America - Market size and forecast 2025-2030
- 12.5.1 US - Market size and forecast 2025-2030
- 12.5.2 Canada - Market size and forecast 2025-2030
- 12.5.3 Mexico - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Australia - Market size and forecast 2025-2030
- 12.6.2 Brazil - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.5 Turkey - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Proliferation of consumer awareness regarding human microbiome and preventive health
- Superior technological stability and versatile formulation capabilities
- Increasing utilization in animal nutrition and veterinary applications
- 13.2 Market challenges
- Regulatory ambiguity and lack of global harmonization
- High production costs and complex manufacturing technologies
- Limited consumer understanding and competition from established biotics
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of postbiotics in dermatological and cosmeceutical applications
- Expansion of postbiotics into active lifestyle and sports nutrition formulations
- Regulatory standardization and clinical validation enhancing commercial credibility
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Adare Pharma Solutions
- Adare Pharma Solutions - Overview
- Adare Pharma Solutions - Product / Service
- Adare Pharma Solutions - Key offerings
- SWOT
- 15.5 Archer Daniels Midland Co.
- Archer Daniels Midland Co. - Overview
- Archer Daniels Midland Co. - Business segments
- Archer Daniels Midland Co. - Key news
- Archer Daniels Midland Co. - Key offerings
- Archer Daniels Midland Co. - Segment focus
- SWOT
- 15.6 Cargill Inc.
- Cargill Inc. - Overview
- Cargill Inc. - Product / Service
- Cargill Inc. - Key news
- Cargill Inc. - Key offerings
- SWOT
- 15.7 DSM Firmenich AG
- DSM Firmenich AG - Overview
- DSM Firmenich AG - Business segments
- DSM Firmenich AG - Key offerings
- DSM Firmenich AG - Segment focus
- SWOT
- 15.8 GeneFerm Biotechnology Co. Ltd
- GeneFerm Biotechnology Co. Ltd - Overview
- GeneFerm Biotechnology Co. Ltd - Product / Service
- GeneFerm Biotechnology Co. Ltd - Key offerings
- SWOT
- 15.9 International Flavors Inc.
- International Flavors Inc. - Overview
- International Flavors Inc. - Business segments
- International Flavors Inc. - Key news
- International Flavors Inc. - Key offerings
- International Flavors Inc. - Segment focus
- SWOT
- 15.10 Kaneka Corp.
- Kaneka Corp. - Overview
- Kaneka Corp. - Business segments
- Kaneka Corp. - Key offerings
- Kaneka Corp. - Segment focus
- SWOT
- 15.11 Kerry Group Plc
- Kerry Group Plc - Overview
- Kerry Group Plc - Business segments
- Kerry Group Plc - Key news
- Kerry Group Plc - Key offerings
- Kerry Group Plc - Segment focus
- SWOT
- 15.12 KitoZyme LLC
- KitoZyme LLC - Overview
- KitoZyme LLC - Product / Service
- KitoZyme LLC - Key offerings
- SWOT
- 15.13 Lallemand Inc.
- Lallemand Inc. - Overview
- Lallemand Inc. - Product / Service
- Lallemand Inc. - Key offerings
- SWOT
- 15.14 Lesaffre Group
- Lesaffre Group - Overview
- Lesaffre Group - Product / Service
- Lesaffre Group - Key offerings
- SWOT
- 15.15 Novonesis Group
- Novonesis Group - Overview
- Novonesis Group - Business segments
- Novonesis Group - Key offerings
- Novonesis Group - Segment focus
- SWOT
- 15.16 Ohly GmbH
- Ohly GmbH - Overview
- Ohly GmbH - Product / Service
- Ohly GmbH - Key offerings
- SWOT
- 15.17 Sabinsa Corp.
- Sabinsa Corp. - Overview
- Sabinsa Corp. - Product / Service
- Sabinsa Corp. - Key offerings
- SWOT
- 15.18 Symrise Group
- Symrise Group - Overview
- Symrise Group - Business segments
- Symrise Group - Key news
- Symrise Group - Key offerings
- Symrise Group - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
